Literature DB >> 19694822

The pathology of depopulated bovine ureter xenografts utilized for vascular access in haemodialysis patients.

Gearoid T Kingston1, Christopher R Darby, Ian S D Roberts.   

Abstract

AIMS: Vascular access for long-term haemodialysis is obtained through the surgical fashioning of arteriovenous fistulae, utilizing the patients' native blood vessels, or by insertion of synthetic grafts or non-synthetic gluteraldehyde cross-linked biological xenografts. These non-native grafts have high complication rates and a depopulated bovine ureter xenograft has recently been developed as an alternative. The aim was to undertake the first systematic review of the histopathology of bovine ureter xenografts (n = 25) utilized for haemodialysis vascular access in humans. METHODS AND
RESULTS: Pre-insertion specimens (n = 7) showed preservation of some cellular architecture and histological antigenicity. Uncomplicated segments of post-insertion specimens (n = 18) showed myofibroblastic in-growth but no luminal endothelialization and no vascularization of the wall, other than at sites of needle puncture. Post-insertion, 50% showed a severe adventitial host inflammatory response with a dominant granulomatous and eosinophil-rich infiltrate. Inflammation was present in grafts with various complications (stenosis, thrombosis, aneurysm), but there was no clear pathogenic link.
CONCLUSIONS: We conclude that repopulation of bovine ureter xenografts by host cells is limited and that, in specimens removed for complications, an inflammatory reaction to the xenograft is common. This could reflect retention of some antigenicity following pre-insertion 'depopulation' of the grafts.

Entities:  

Mesh:

Year:  2009        PMID: 19694822     DOI: 10.1111/j.1365-2559.2009.03360.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  2 in total

1.  Bioengineered human acellular vessels for dialysis access in patients with end-stage renal disease: two phase 2 single-arm trials.

Authors:  Jeffrey H Lawson; Marc H Glickman; Marek Ilzecki; Tomasz Jakimowicz; Andrzej Jaroszynski; Eric K Peden; Alison J Pilgrim; Heather L Prichard; Malgorzata Guziewicz; Stanisław Przywara; Jacek Szmidt; Jakub Turek; Wojciech Witkiewicz; Norbert Zapotoczny; Tomasz Zubilewicz; Laura E Niklason
Journal:  Lancet       Date:  2016-05-14       Impact factor: 79.321

2.  Acute Phase Pilot Evaluation of Small Diameter Long iBTA Induced Vascular Graft "Biotube" in a Goat Model.

Authors:  Ryuji Higashita; Yasuhide Nakayama; Yasuyuki Shiraishi; Ryosuke Iwai; Yusuke Inoue; Akihiro Yamada; Takeshi Terazawa; Tsutomu Tajikawa; Manami Miyazaki; Mamiko Ohara; Tadashi Umeno; Keitaro Okamoto; Tomonori Oie; Tomoyuki Yambe; Shinji Miyamoto
Journal:  EJVES Vasc Forum       Date:  2022-01-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.